Answers are grounded in this paper and cite their sources.
The use of anti-copper agents in clinically pre-symptomatic patients diagnosed with WD allows clinically overt disease to be effectively prevented. However, compliance with therapy is extremely important.
No takes yet. Share an insight, caveat, or question.
Dzieżyc et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: